Drug Type Prophylactic vaccine |
Synonyms Adjuvanted TB subunit vaccine H56IC, H56/IC31 vaccine, Tuberculosis vaccine H56IC + [6] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Tuberculosis | Phase 2 | ZA | 31 Jan 2019 | |
Pulmonary Tuberculosis | Phase 2 | TZ | 31 Jan 2019 | |
Tuberculosis | Phase 2 | ZA | - | 27 Jan 2019 |
Latent Tuberculosis | Phase 2 | ZA | 01 Aug 2013 | |
Tuberculosis, Multidrug-Resistant | Phase 1 | NO | - | 01 Nov 2015 |
Phase 1 | 84 | (Group 1 H4:IC31) | zijbutoehq(jmcruayhhl) = bcqigaovlm tiwwjuubyi (znwtkypoiz, jkkesyxdbh - dyukczgqxo) View more | - | 18 Nov 2019 | ||
(Group 2 H56:IC31) | zijbutoehq(jmcruayhhl) = ivicedvdev tiwwjuubyi (znwtkypoiz, evyoodkbpk - vgygzuolcc) View more | ||||||
Phase 1 | 22 | Placebo (Placebo) | ckexkbqgqt(bppmxskwmv) = ktxpjhnodd juqdaotrnf (eyatmzzpjx, khruitdtfu - ahdizosxqw) View more | - | 18 Nov 2019 | ||
(Gr 1 H56:IC31 5/500) | chhpkuuwcn(jbytmijeth) = fnbmygqttv qkjhawqsjg (xzqhlsjwgp, xxngukailc - qhnyjkksuc) View more | ||||||
Phase 1 | 25 | (H56:IC31 (50 ug H56) LTBI Neg) | fuypvglgrv(ywsaleztvn) = huqhztnvfm ruftsyesui (fvbikpxgqp, dgkgogcxwm - egexpjygpg) View more | - | 21 Aug 2019 | ||
(H56:IC31 (15 ug H56) LTBI Pos) | fuypvglgrv(ywsaleztvn) = nvnwdvrmre ruftsyesui (fvbikpxgqp, zdcjhqmpzw - sgwvszwbxs) View more |